Neuphoria Therapeutics Inc. (NEUP) Form 8-K — Oct 23, 2026
$NEUPForm 8-KItems 1.01, 3.03, 9.01Filed Oct 23, 2026, 8:00 AM ET0001213900-26-111863Original filing
Neuphoria Therapeutics amended its shareholder rights agreement, extending the Final Expiration Date to the close of business on October 27, 2027. The original rights plan was dated October 27, 2025, with Computershare Trust Company acting as rights agent. The amendment was made under Section 27 of the Rights Agreement without shareholder approval, and the Company notes the Rights remain redeemable. The 8-K was signed by Interim CEO Spyridon Papapetropoulos.
Key figures
- Rights plan original date
- 2025-10-27
- Rights plan new expiration
- 2027-10-27
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.